Waters Muddied As Bharat Readies COVID-19 Vaccine For '21 Launch

Questions Over Phase I Adverse Event

Questions Arise Over Bharat Biotech's Handling Of An Adverse Event • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

More from COVID-19

More from Scrip